Claman Countdown | Latest Episodes

Stifel CEO Ron Kruszewski discusses Anthropic's amended S-1 filing to offer 825 million shares ahead of its Nasdaq debut on ‘The Claman Countdown.’

Oracle CFO Hilary Maxson discusses the company's fiscal 2030 targets, including a $225 billion revenue goal, on 'The Claman Countdown.'

ERShares CIO & COO Eva Ados discusses the versatility of SpaceX and a unique EFT for pre-IPO investors on ‘The Claman Countdown.’

Schwab Center for Financial Research chief investment strategist Liz Ann Sonders discusses the reasons behind recent market volatility on 'The Claman Countdown.'

NYU professor emeritus Gary Marcus and former NSA analyst Ira Winkler examine espionage concerns, corporate governance questions and potential fallout for Nvidia amid allegations involving CEO Jensen Huang on ‘The Claman Countdown.’

HB Wealth chief market strategist Gina Martin Adams discusses falling oil prices and their impact on the stock market and breaks down the S&P 500 rebound on ‘The Claman Countdown.’

BlackRock U.S. head of equity ETFs Jay Jacobs discusses Nvidia's market slide and ways investors can buffer against market downsides on 'The Claman Countdown.'

Poppi co-founder Allison Ellsworth announces the launch of Jetty, a new everyday electrolyte beverage that aims to disrupt the hydration market with lower sugar and prebiotic fiber, on ‘The Claman Countdown.’

Raymond James Investment Management chief market strategist Matt Orton joins 'The Claman Countdown' to discuss economic trends and predictions following Tuesday's midterm blue wave.

Motley Fool Asset Management chief investment strategist Bill Mann discusses his top healthcare stock picks and navigating an uncertain market on ‘The Claman Countdown.’

Eurasia Group founder and President Ian Bremmer analyzes the prospect of renewed U.S. strikes on Iran, the shifting dynamics of the conflict between Russia and Ukraine and more on ‘The Claman Countdown.’

Doximity CEO Jeff Tangney discusses what his company is doing to shape the future of artificial intelligence in healthcare and how his platform is being used today on 'The Claman Countdown.'

BD chairman and CEO Tom Polen discusses the company's quarterly sales, earnings estimates, and the impact of tariffs on MedTech on 'The Claman Countdown'.

UBS managing director Jason Katz and Slatestone Wealth chief market strategist Kenny Polcari analyze the market sell-off, surging bond yields and performance of major financial stocks on ‘The Claman Countdown.’

IMAX CEO Rich Gelfond joins 'The Claman Countdown' to discuss how Christopher Nolan's 'The Odyssey' drove in record third-quarter results.

Arm CEO Rene Haas joins ‘The Claman Countdown’ to break down the chipmaker’s record second-quarter revenue and surging demand from AI data centers.

Qualcomm President and CEO Cristiano Amon discusses the company's year-end earnings and what to expect in 2027 on 'The Claman Countdown.'

Fox News contributors Jessica Tarlov and Joe Concha analyze the midterm election results and discuss how inflation and rising cost of living concerns influenced voters at the ballot box on 'The Claman Countdown.'

Tema ETFs head of investment strategy Paisley Nardini shares stock picks following a Democratic sweep in Congress on ‘The Claman Countdown.’

SMBC America chief economist Joe LaVorgna joins ‘The Claman Countdown’ to break down the market rally as the S&P 500 posts its best day in seven months following the midterm elections.